The Claim

In adults aged 50–85 with high-risk age-related macular degeneration and the lowest dietary intake of lutein and zeaxanthin (bottom quintile), daily supplementation with lutein (10 mg) and zeaxanthin (2 mg) was associated with a 26% lower risk of progression to advanced age-related macular degeneration (hazard ratio 0.74, 95% confidence interval 0.59–0.94; P = .01).

Source: Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
74score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Correlation
1 study reviewed
In plain English

Among older adults with advanced eye disease and very low dietary intake of lutein and zeaxanthin, taking 10 mg of lutein and 2 mg of zeaxanthin daily was linked to a 26% reduction in the risk of the disease worsening.

See the scientific wording

In adults aged 50–85 with high-risk age-related macular degeneration and the lowest dietary intake of lutein and zeaxanthin (bottom quintile), supplementation with lutein (10 mg) and zeaxanthin (2 mg) daily was associated with a 26% lower risk of progression to advanced AMD (HR 0.74, 95% CI 0.59–0.94; P = .01), though this subgroup finding was not pre-specified and may reflect chance.

Why this might work

When lutein and zeaxanthin are consumed, they enter the bloodstream and travel to the back of the eye, where they build up in a protective layer called the macular pigment. This layer blocks harmful blue light and neutralizes damaging molecules produced by light exposure, which prevents the slow breakdown of light-sensitive cells in the retina. In people who eat very little of these nutrients, adding them back stops this breakdown from getting worse.

Verified mechanismbased on 1 study

What the research says

1 study
  1. Study: Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.

    For older adults with serious eye disease who eat very little of these nutrients, taking lutein and zeaxanthin supplements was linked to a lower chance of their vision getting worse — even if the study wasn’t originally designed to test this group.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.